(Q34809901)

4 August 2017

title

Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization (English)

1 reference

4 August 2017

Anne Dekeyne

1

1 reference

4 August 2017

Mark J Millan

series ordinal

2

1 reference

4 August 2017

publication date

16 August 2008

1 reference

4 August 2017

number of pages

13

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

4 August 2017

volume

203

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

329-341

1 reference

A Review of the Pharmacological and Clinical Profile of Mirtazapine

4 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1259-8

Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1259-8

Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1259-8

Preclinical evidence on the psychotropic profile of fluvoxamine

21 January 2018

1 reference

12 December 2020

Antagonism of the stimulus effects of yohimbine and 8-hydroxydipropylaminotetralin

1 reference

12 December 2020

Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin.

1 reference

12 December 2020

Discriminative stimulus properties of eltoprazine

1 reference

12 December 2020

Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.

1 reference

12 December 2020

Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats

1 reference

12 December 2020

1 reference

12 December 2020

Discriminative stimulus properties of tianeptine

1 reference

12 December 2020

Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro

1 reference

12 December 2020

Discriminative stimulus properties of antidepressant agents: a review

1 reference

12 December 2020

The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission

1 reference

12 December 2020

Antagonism of selective serotonin reuptake inhibitor-induced nausea by mirtazapine

1 reference

12 December 2020

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

1 reference

12 December 2020

S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

1 reference

12 December 2020

Mianserin as a discriminative stimulus in rats: asymmetrical cross-generalization with scopolamine

1 reference

12 December 2020

Mirtazapine: a review of its clinical efficacy and tolerability

1 reference

12 December 2020

Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine

1 reference

12 December 2020

Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction

1 reference

12 December 2020

Role of serotonin(2C) receptors in the control of brain dopaminergic function

1 reference

12 December 2020

1 reference

12 December 2020

Safety of antidepressants in the elderly

1 reference

12 December 2020

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

1 reference

12 December 2020

Endocrinological effects of mirtazapine in healthy volunteers

1 reference

12 December 2020

Effects of antidepressants in rats trained to discriminate centrally administered isoproterenol

1 reference

12 December 2020

Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies

1 reference

12 December 2020

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram

1 reference

12 December 2020

The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors

1 reference

12 December 2020

Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline

1 reference

12 December 2020

Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release

1 reference

12 December 2020

Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats.

1 reference

12 December 2020

Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression

1 reference

12 December 2020

Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan

1 reference

12 December 2020

Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action

1 reference

12 December 2020

The neurobiology and control of anxious states

1 reference

12 December 2020

5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review

1 reference

12 December 2020

The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats

1 reference

12 December 2020

S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

1 reference

12 December 2020

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

1 reference

12 December 2020

Mirtazapine acutely inhibits basal and K(+)-stimulated release of corticotropin-releasing hormone from the rat hypothalamus via a non-genomic mechanism

1 reference

12 December 2020

Adaptation of brain 5HT2 receptors after mianserin treatment: receptor sensitivity, not receptor binding, more accurately correlates with behavior.

1 reference

12 December 2020

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

12 December 2020

Nicotine and bupropion share a similar discriminative stimulus effect

1 reference

12 December 2020

A review of the pharmacological and clinical profile of mirtazapine

1 reference

12 December 2020

Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505

1 reference

12 December 2020

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

12 December 2020

Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice.

1 reference

12 December 2020

5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats.

1 reference

12 December 2020

Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission

1 reference

12 December 2020

Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle.

1 reference

12 December 2020

Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses

1 reference

12 December 2020

Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models

1 reference

12 December 2020

Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice

1 reference

12 December 2020

5-HT3 receptor ligands lack discriminative stimulus properties

1 reference

12 December 2020

Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.

1 reference

12 December 2020

Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus

1 reference

12 December 2020

The selective serotonin(2A) receptor antagonist, MDL100,907, elicits a specific interoceptive cue in rats

1 reference

12 December 2020

Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex

1 reference

12 December 2020

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

12 December 2020

Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine

1 reference

12 December 2020

Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone

1 reference

12 December 2020

Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control

1 reference

12 December 2020

Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo

1 reference

12 December 2020

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

12 December 2020

Anxiolytics antagonize yohimbine's discriminative stimulus properties

1 reference

12 December 2020

The discriminative stimulus effects of clomethiazole in the rat.

1 reference

12 December 2020

Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies

1 reference

12 December 2020

The 5-HT1A receptor agonist flesinoxan shares discriminative stimulus properties with some 5-HT2 receptor antagonists.

1 reference

12 December 2020

Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine.

1 reference

12 December 2020

Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

1 reference

12 December 2020

Imipramine as a discriminative stimulus

1 reference

12 December 2020

Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in rats

1 reference

12 December 2020

Study of mirtazapine antidepressant effects in rats

1 reference

12 December 2020

Additional evidence that l-5-hydroxytryptophan discrimination models a unique serotonin receptor

1 reference

12 December 2020

Does mirtazapine enhance serotonergic neurotransmission in depressed patients?

1 reference

12 December 2020

Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole.

1 reference

12 December 2020

Cardiovascular effects of antidepressant drugs: updated

1 reference

12 December 2020

Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols

1 reference

12 December 2020

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

12 December 2020

Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine

1 reference

12 December 2020

10.1007/S00213-008-1259-8

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1036317371

0 references

1 reference